| Description |
vi, 80 pages ; 25 cm |
| Series |
Senate Committee Report / Legislative and General Purpose Standing Committee |
|
Australia. Parliament. Senate. Standing Committee on Community Affairs.
Report
|
| Summary |
"Positron Emission Tomography (PET) is a diagnostic imaging technology that uses short-lived radioisotopes to enable the non-invasive imaging of metabolic functions within the body. To conduct the scan a short-lived radioactive tracer isotope, which decays by emitting a positron and which has been chemically incorporated into a metabolically active molecule, is injected into a patient. The molecule most commonly used for this purpose is fluorodeoxyglucose (FDG). While computed tomography (CT) and magnetic resonance imaging (MRI) primarily provide information about anatomical structure, PET can image and quantify biochemical and/or physiological function. PET can be used as a means of diagnosis for a range of clinical conditions, including many cancers. The widespread use of PET is limited by the costs of cyclotrons required to produce the materials used for PET scanning as well as the need for trained staff and specialised equipment'--P. 2 |
| Notes |
"June 2008" |
|
"The Senate" |
|
"Senator Claire Moore, Chair"--P. iii |
| Bibliography |
Includes bibliographical references |
| Notes |
Commonwealth of Australia 2008 |
| Subject |
Tomography, Emission -- Australia.
|
|
Radioisotopes in medical diagnosis -- Australia.
|
|
Electrodiagnosis -- Australia.
|
| Author |
Moore, Claire.
|
| ISBN |
9780642718679 |
|
